Desoxycorticosterone

Desoxycorticosterone

SCHEMBL9504254

CC(=O)O.C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Desoxycorticosterone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 8/20 0.94
▸ SMN1; SMN2 Q16637 7/20 0.94
▸ ALDH1A1 P00352 6/20 0.94
▸ CYP3A4 P08684 6/20 0.94
▸ MAPT P10636 6/20 0.94
▸ MAPK1 P28482 5/20 0.94
▸ SHBG P04278 3/20 0.94
▸ SERPINA6 P08185 3/20 0.94
▸ HSD17B10 Q99714 3/20 0.94
▸ ABCB11 O95342 2/20 0.94
▸ HIF1A Q16665 4/20 0.77
▸ CYP2C9 P11712 3/20 0.77
▸ TSHR P16473 3/20 0.77
▸ NR3C2 P08235 3/20 0.77
▸ MEN1 O00255 2/20 0.77
▸ KMT2A Q03164 2/20 0.77
▸ NR1I2 O75469 2/20 0.77
▸ NR3C1 P04150 2/20 0.77
▸ PGR P06401 2/20 0.77
▸ SLC22A2 O15244 2/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Desoxycorticosterone SCHEMBL21243062 0.97 LMNA (1.00) LMNASMN1; SMN2ALDH1A1CYP3A4MAPT
Desoxycorticosterone SCHEMBL28269906 0.97 LMNA (1.00) LMNASMN1; SMN2ALDH1A1CYP3A4MAPT
Desoxycorticosterone SCHEMBL25773308 0.97 LMNA (1.00) LMNASMN1; SMN2ALDH1A1CYP3A4MAPT
Desoxycorticosterone SCHEMBL13752803 0.97 LMNA (1.00) LMNASMN1; SMN2ALDH1A1CYP3A4MAPT
Desoxycorticosterone SCHEMBL4065 0.97 LMNA (1.00) LMNASMN1; SMN2ALDH1A1CYP3A4MAPT
Desoxycorticosterone SCHEMBL4066 0.97 LMNA (1.00) LMNASMN1; SMN2ALDH1A1CYP3A4MAPT
Desoxycorticosterone SCHEMBL15763287 0.97 LMNA (1.00) LMNASMN1; SMN2ALDH1A1CYP3A4MAPT
Desoxycorticosterone SCHEMBL18891475 0.97 LMNA (1.00) LMNASMN1; SMN2ALDH1A1CYP3A4MAPT
Desoxycorticosterone SCHEMBL10593143 0.95 LMNA (0.92) LMNASMN1; SMN2ALDH1A1CYP3A4MAPT
Progesterone SCHEMBL7714079 0.90 LMNA (0.88) LMNASMN1; SMN2ALDH1A1CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11906510-B2 Metabolic profiling by reverse-phase/ion-exchange mass spectrometry STANFORD JUNIOR UNIVERSITY (US) 2024-02-20 — — US disclosed
US-20210364498-A1 METABOLIC PROFILING BY REVERSE-PHASE/ION-EXCHANGE MASS SPECTROMETRY THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2021-11-25 — — US disclosed
EP-0414931-B1 HYPOTENSIVE AGENT TANABE SEIYAKU CO (JP) 1993-07-14 — — EP disclosed
EP-0414931-A1 Hypotensive agent TANABE SEIYAKU CO., LTD. (JP) 1991-03-06 — — EP disclosed
Send feedback